Cite
25P Improving efficacy and reducing toxicity of anti-PD-L1 treatment: T-cells as delivery vehicles for anti-PD-L1 blocking nanobodies.
MLA
Petit, P. F., et al. “25P Improving Efficacy and Reducing Toxicity of Anti-PD-L1 Treatment: T-Cells as Delivery Vehicles for Anti-PD-L1 Blocking Nanobodies.” Annals of Oncology, vol. 31, Dec. 2020, p. S1425. EBSCOhost, https://doi.org/10.1016/j.annonc.2020.10.511.
APA
Petit, P.-F., Zhu, J., & van den Eynde, B. J. (2020). 25P Improving efficacy and reducing toxicity of anti-PD-L1 treatment: T-cells as delivery vehicles for anti-PD-L1 blocking nanobodies. Annals of Oncology, 31, S1425. https://doi.org/10.1016/j.annonc.2020.10.511
Chicago
Petit, P-F., J. Zhu, and B.J. van den Eynde. 2020. “25P Improving Efficacy and Reducing Toxicity of Anti-PD-L1 Treatment: T-Cells as Delivery Vehicles for Anti-PD-L1 Blocking Nanobodies.” Annals of Oncology 31 (December): S1425. doi:10.1016/j.annonc.2020.10.511.